Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Announces 91% Sequential Growth to $1.35 Million and Significant Financial Improvements

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. and California cannabis marketplaces, today announced robust growth and significant financial improvements for the most recently completed financial period ending Dec. 31, 2019. Cannabis Strategic Ventures reported revenue of $1.35 million for the quarter ending Dec. 31, representing approximately 91% sequential growth compared to the previous quarter. According to the update, gross margins grew meaningfully while operating efficiencies significantly improved. “We’re excited to see consistent revenue growth,” Simon Yu, CEO of the Company, said in the news release.  “In this highly regulated environment, it takes time to scale production.  With a considerable portion of the permitting and construction behind us, we are poised for continued growth in the California cannabis marketplace.”

To view the full press release, visit http://cnw.fm/w4OV7

About Cannabis Strategic Ventures

Cannabis Strategic Ventures, Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The Company is Los Angeles-based that incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing Cannabis consumer brands. For more information, visit www.CannabisStrategic.com

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://cnw.fm/NUGS

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – What Pot Companies Can Learn from Federal Hemp Legalization

The National legalization of hemp under the 2018 Farm Bill provides marijuana business with essential lessons to use when preparing for a highly analyzed, commodity-driven industry. The lessons would especially be valuable to small companies that are well managed.

The co-founder and president of the American Trade Association for Marijuana and Hemp, Michael Bronstein, said that although hemp and marijuana are different industries, marijuana can learn some few things from the national rollout of hemp.

Experts advise companies to anticipate changes in the marijuana industry, even if it takes a few more years before marijuana can be legalized at the federal level. The companies should become more professional in their operations by adopting standards from other industries that are highly regulated.

Bronstein said that companies, whether they are specializing in the production of CBD, THC, or both, should adopt best practices and participate responsibly in the industry.

The co-founder of Canna Advisors Diane Czarkowski said that companies should expect constant changes as well as more regulations in the industry. Canna Advisors is based in Colorado and offers several consulting services to marijuana and hemp companies.

Discussed below are some of the lessons marijuana companies should learn from the national legalization of hemp:

  1. It will take a while to develop federal rules

After the enactment of federal reforms on marijuana law, there is a possibility that cannabis policy development will drag. The chief of the National Hemp Association in Washington DC, Geoff Whaling, said that it is going to take years before hemp policies are implemented.

The USDA took 11 months to finalize interim final rules for hemp, and it continues working on them. And more months had to elapse before financial institutions could accept to serve the hemp industry.

  1. Expect federal and state oversight

After the federal legalization of marijuana, there would be a lot of scrutiny from several federal agencies such as USDA, FDA, and DEA. Therefore, marijuana companies should be prepared on how to deal with the regulations, how to implement them, and their impact on their businesses.

Bronstein said that his trade group is collaborating with state regulators in the development of standard testing, devices and appliances, transport, quality management, security, and track and trace systems. These will come in handy after the federal legalization of marijuana.

Companies should also anticipate inter-state marijuana businesses.

  1. Prepare for green rush 2.0

In the U.S., the pot sector has already experienced a ‘green rush,’ and another rush might happen after cannabis is legalized federally.

The executive director of the U.S. Hemp Growers Association, Caren Wilcox, said that in January 2019, the hemp industry experienced a rush where every farmer wanted to plant hemp. If this happens in the marijuana industry, only farmers with strong skills and are savvy in business would survive and thrive.

  1. Prices to fall as marijuana becomes a commodity

According to a senior attorney at McAllister Garfield, David Wunderlich, after commoditization of marijuana, cannabis companies should expect a drop in the price of retail and wholesale pot. The law firm specializes in hemp and marijuana law.

Wunderlich noted that since hemp was legalized, the price per kg has dropped to $1,000-$1,500 from $6,000-$7,000.

Industry experts have predicted that marijuana will become more of a commodity after it is federally legalized.

Wunderlich further said that marijuana companies should include several assumptions in their models and not assume that after legalization, the prices will remain constant and overinvest.

He also noted that a drop in prices affects the supply chain, which may result in a breach of contract, and delays in delivery.

According to experts, these are serious concerns that cannabis companies like Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) may be thinking about since only the companies that can quickly adapt to the evolving landscape will survive the initial surge of players once pot is legalized federally in the U.S.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Vermont House Passes Marijuana Legalization Bill

On Thursday, the House of Representatives in Vermont approved a bill legalizing retail sales of marijuana. However, the Governor, Phil Scott (R), said that he is not happy with one of the key components of the legislation.

On Wednesday, the measure garnered a strong initial vote in the House, but for the bill to formally clear the chamber, an additional vote was required, and the Members of the chamber gave a third reading approval to the legislation through a voice vote.

The approval of the measure in the Chamber was preceded by the action of the following committees; the House Government Operations, Ways and Means, and Appropriations committees where they amended and cleared the bill in the past few weeks.

In 2018, Vermont legalized the cultivation and possession of marijuana for personal use; however, the state has no legal means of purchasing/selling weed. The current legislation would resolve the purchasing challenge by establishing a commercial marijuana market. Through the bill, the state would also create several business permits and set tax rates to be imposed on legal marijuana sales.

In 2019, during the first half of the two-year legislative session, the Senate approved S. 54 in a vote of 23 to 5, and now the House and the Senate are expected to appoint a bicameral conference committee to resolve the differences between the two versions of the legislation.

Before the House made the final vote on Thursday, it took up the following amendments:

  • In a voice vote, the lawmakers adopted a proposal prohibiting the advertisement of marijuana businesses but excluded labels on products, or educational and editorial materials.
  • They also approved a proposal clarifying marijuana product tests would be paid for by the Department of Public Safety using the Business licensing fees instead of funds from its regulatory budget, in a voice vote.

In a vote of 48-93, the chamber rejected an amendment to expand public disclosure requirements for marijuana business applicants and their investors.

In a voice vote of 27-117, the chamber also rejected an amendment stating that law enforcement should administer saliva and breathalyzer tests in private to individuals suspected of driving under the influence. As per the bill, the samples would not be taken at the roadside, would not be used as evidence in court proceedings, and could not be used as a probable cause for arrest.

Vermont’s Governor has been pushing for law enforcement to be allowed to conduct such tests without a hassle. Scott said that impaired driving is one of the main reasons why he is opposed to commercial legalization of marijuana.

There is uncertainty on the governor’s action once the bill gets to his desk. After the House voted on Thursday, the governor said that he is not happy about the stipulation that the police must first obtain a warrant before conducting the saliva test.

Scott said that marijuana testing should be treated the same as alcohol because police officers do not need to obtain a warrant to administer alcohol impairment testing.

Top lawmakers in Vermont and administration officials said that the governor is involved in discussions about the latest marijuana reform as he is open to using tax proceeds from pot to fund an after-school program he is advocating for. On Wednesday, the chamber approved an amendment to provide funding for such initiatives.

A poll conducted by the Marijuana Policy Project found that out of four residents of Vermont, three were in favor of allowing adults to purchase cannabis.

It remains to be seen what marijuana companies like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) suggest as the best way to harmonize the position of the lawmakers and the governor so that the people of Vermont can have a chance to buy the marijuana products they may need.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempNewsBreaks – MCTC Holdings, Inc. (MCTC) to Host Hemp You Can Feel(TM) Alcohol-Free Cocktails Launch Event for LA Press

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced an upcoming press event it plans to host on March 12, 2020, to introduce its new Hemp You Can Feel(TM) Alcohol-Free cocktails. The event will feature some of the Los Angeles area’s best bartenders and servers as they mix up both classic and new age hemp-infused cocktails based on MCTC’s next-generation all-natural hemp extract and CBD beverage infusion technologies. “When was the last time you were able to relax with a cocktail, but not have to worry about the negative effects of alcohol?” MCTC Chief Executive Officer Arman Tabatabaei said in the news release. “We have invented something truly extraordinary with our Hemp You Can Feel(TM) technology – In fact, it is so unique, we have filed several patents on the underlying technologies. We invite all area presses to be among the first to try these all-natural hemp extract and CBD cocktails.”

To view the full press release, visit http://cnw.fm/RO1fI

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. More information on the Company can be viewed at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) PharmHouse Receives Health Canada License Amendment for Cultivation Across Entire Greenhouse

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its 49%-owned joint venture in Leamington, Ontario, PharmHouse Inc., received a license amendment from Health Canada allowing for cultivation across its entire greenhouse, which is now fully operational. According to the update, PharmHouse plans immediate ramp up in production in accordance with its offtake agreements with Canopy Growth Corporation and TerrAscend Canada Inc. Under these agreements, PharmHouse has committed 50% of its 2020 output and currently expects to use the remaining 50% of its capacity for both additional offtake agreements and its own private label brand. “The receipt of our license amendment represents a large milestone for PharmHouse,” PharmHouse General Manager Tony Abbas said in the news release. “This is a reflection of the hard work and dedication that our team has put in this past year and we are all very excited for this next chapter. Since the inception of PharmHouse, it has been our goal to bring innovation and consistency to greenhouse cannabis cultivation. With our full production capacity available to us and with the experience and market presence of our partners, we hope to change the industry concept of commercial cannabis production.”

To view the full press release, visit http://cnw.fm/RcP6i

About Canopy Rivers

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire portfolio. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Chair, Paul Lucas, Recipient of Life Sciences Ontario’s Lifetime Achievement Award

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that its chair of its board of directors, Paul Lucas, is the receipt of the 2020 Lifetime Achievement Award from Life Sciences Ontario. The award recognizes Lucas’ exceptional leadership and contributions to the development of the life sciences sector in Canada, his commitment to the community and his passion for improving the quality of life for Canadians. “We are proud and honoured to have the benefit of Paul’s knowledge and expertise as we continue to grow VIVO’s business,” VIVO CEO Barry Fishman said in the news release. “Paul’s career is marked by outstanding achievements, unwavering dedication and commitment to the life sciences community. We are incredibly fortunate to have Paul as the Chair of VIVO, setting the standard for integrity, strategic focus and governance in this nascent industry.”

To view the full press release, visit http://cnw.fm/jI7ri

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine service. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VIVOCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Trial Shows Medical Marijuana Can Treat Insomnia

Zelira Therapeutics has developed a medical marijuana insomnia product known as Thunderbird. Zelira Therapeutics was previously called Zelda Therapeutics (ASX: ZLD), and it changed its name after merging with the USA’s Ilera Therapeutics LLC late last year.

For the past few years, Zelda, currently known as Zelira Therapeutics, has been working on a marijuana product used for treating insomnia, ZLT-101. In 2017,  Zelda Therapeutics obtained approval to conduct clinical trials with patients who have chronic insomnia in Australia. At the time of the merger, Zelda Therapeutics was also studying the use of marijuana in treating conditions such as autism, cancer, and opioid reduction, and it will continue to do so under the new company.

Zelira Therapeutics has operations both in the U.S. and Australia, and this gives it a robust platform in the global medical marijuana market.

On Wednesday, Zelira Therapeutics announced that it had completed phase 1b/2a of the clinical trials of ZLT-101. The study findings reveal that 23 patients who had chronic insomnia and were treated using ZLT-101 demonstrated statistical improvement in the Insomnia Severity Index (ISI) scores when they were compared with those who used the placebo. Patients who used ZLT-101 showed high tolerance since no adverse effects were reported.

Although ZLT-101 was well tolerated, some patients said that they experienced the following side effects; dry mouth, which was preceded by dizziness, headache, and feeling unwell. Out of the 23 patients using ZLT-101, 17 reported having experienced these mild side effects. Four participants who were placed on the placebo also said that they experienced the same side effects.

Zelira Therapeutics said that all adverse events that were noted during the clinical trials were classified as mild, and 97.5% of the cases had resolved overnight or as soon as the patient woke up the following day or were resolved at the end of the clinical trial.

Zelira said that lack of severe or persistent mild adverse cases is encouraging, given those linked with other insomnia therapies.

Prof. Peter Eastwood, who was the Principal Investigator for the study, said that it was impressive for the ZLT-101 treatment to achieve a statistically significant improvement in ISI scores, given the relatively short two-week dosing window. Prof. Eastwood is also the director of the Centre for Sleep Science, which is based at the University of Western Australia.

Although the clinical trial findings won’t be published until the end of March 2020, the Chairman of Zelira Osagie Imasogie said that the company can now commercialize ZLT-101 across the globe this year.

Patients who have chronic insomnia have challenges sleeping or staying asleep. They do not feel refreshed even after adequate sleep, and they also suffer from impairment during their day-to-day activities for a minimum of four weeks.

It is widely expected that other marijuana industry players, such as SinglePoint Inc. (OTCQB: SING), are happy that these research findings are positive since they add to the increasing body of evidence proving the therapeutic effects of marijuana on various health conditions.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – New Mexico Moves to End Access to Medical Marijuana by Non-Residents

New Mexico has ruled out the enrollment of non-resident in their medical marijuana program. This week, New Mexico governor Michelle Lujan Grisham signed into law a bill that denies issuance of medical marijuana cards to non-residents.

Last year the state approved a change in statute, which was signed by the governor, allowing out of state patients to enroll in the state’s medical marijuana program. And since September, more than 600 patients from Texas, Arizona, and other states have enrolled in the New Mexico medical marijuana program. Under the new law, the patients will not be able to renew their medical marijuana cards in New Mexico, but under the reciprocity rule, they will still be able to buy medical marijuana in New Mexico using their state’s medical marijuana cards.

New Mexico health officials later backtracked and said that the residency requirement provision was removed from the legislation unintentionally. They requested the lawmakers to reinstate the residency requirement this year and claimed that opening the state medical marijuana program to other states might attract federal intervention. Interstate transportation of marijuana is still illegal, and allowing non-residents access to the state’s medical marijuana program might tempt people to transport weed across the borders illegally.

On Monday, New Mexico approved the reinstatement of the residency requirement in a vote of 44-19. The state’s largest medical marijuana distributor, Ultra Health, was against the restoration of the residency requirement. The New Mexico governor also signed reciprocity rules allowing patients with medical marijuana cards from other states to access medical marijuana from New Mexico dispensaries.

The CEO of Ultra Health Duke Rodriguez challenged the claim of federal intervention before the lawmakers, noting that out of state patients adhere to the terms of New Mexico’s medical marijuana program as they seek relief from their health ailments such as cancer and other medical conditions that require marijuana prescriptions.

Speaking to the House committee on health policy, Rodriguez said that there is no threat of federal intervention.

Last year, Ultra Health went to court to compel the state to issue medical marijuana cards to non-residents and succeeded; however, their success was short-lived since the state approved a law reinstating the residency requirement.  Ultra Health has more than 20 dispensaries within the state, and it has been in conflict with the state’s Health Department because it is pushing for an increase in marijuana production caps to ensure that the supply is sufficient to serve the patients.

During the residency reinstatement vote, Democratic House Speaker Brian Egolf excused himself from the debate and the vote since he represents Ultra Health as a private attorney.

Non-residents who are already enrolled in the state’s medical marijuana program and have medical marijuana cards would be allowed to use their cards for a period of three years with no chance of renewal, said the state’s Health Secretary Kathyleen Kunkel.

Four states border New Mexico, and all have legalized medical marijuana, but Texas is notable for only allowing the sale of medical marijuana containing low THC levels. And Colorado has legalized the recreational sale and use of marijuana.

It remains to be seen whether other sector players, such as HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), will react to this measure that appears to take New Mexico a step back on matters of marijuana policy reform.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

HempNewsBreaks – Youngevity International, Inc.’s (NASDAQ: YGYI) Khrysos Industries Hosts First HIAF Educational Event of 2020 at its Orlando-Based Headquarters

Youngevity International (NASDAQ: YGYI) together with its subsidiary and hemp enterprise, Khrysos Industries, Inc., today announced that Khrysos, on Thursday, hosted the first educational and networking event of 2020 for the Hemp Industry Association of Florida (“HIAF”) at its Orlando-based headquarters. According to the update, industry leaders from Florida’s hemp sector and other HIAF board members were treated to a “Hemp Extraction Lab Tour & Workshop” at Khrysos Industries, which operates the largest processing facility in Florida. HIAF, state and federal regulatory updates were also provided during the event. “It was a high honor to host the first HIAF educational event of 2020 and to have the chance to share our vision and capabilities with Florida’s leaders in the Hemp Industry,” YGYI President and CFO Dave Briskie said in the news release. “Dwayne Dundore gave a fantastic presentation and a large group of influencers learned all about Khrysos Industries and its significant capabilities.”

To view the full press release, visit http://cnw.fm/T75ng

About Youngevity International, Inc.

YGYI, Inc. (NASDAQ: YGYI), is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution(R) Coffee company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For investor information, please visit www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) CEO Discusses Launch of Two New Products on MoneyTV with Donald Baillargeon

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives that offer insights into various companies and their operations and future outlooks. Among other highlights, this week’s program featured CIIX CEO Warren Wang as he analyzed the impact of the Coronavirus scare. He discussed the launch of two new products through the company’s China-based subsidiary, CBD Biotech, including a CBD hemp gel as well as a spray, designed to create an isolating mist for consumers in public places.

To view the full press release, visit http://cnw.fm/A6w85

About ChineseInvestors.com Inc.

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.